<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2020-26-6-676-687</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-1933</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Особенности мозгового кровотока у пациентов с хронической обструктивной болезнью легких, ассоциированной с артериальной гипертензией</article-title><trans-title-group xml:lang="en"><trans-title>Features of cerebral blood flow in patients with chronic obstructive pulmonary disease associated with hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7674-2893</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полетаева</surname><given-names>Н. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Poletaeva</surname><given-names>N. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полетаева Нина Борисовна — ассистент кафедры поликлинической терапии, ультразвуковой и функциональной диагностики </p><p>ул. Репина, д.3, Екатеринбург, 620028</p><p>Тел.: 8(343)338–07–87</p></bio><bio xml:lang="en"><p>Nina B. Poletaeva, MD, Assistant, Department of Outpatient Therapy, Ultrasound and Functional Diagnostics, Faculty of General Medicine </p><p>3 Repin str., Ekaterinburg, 620028 </p><p>Phone: 8(343)338–07–87 </p></bio><email xlink:type="simple">ninanova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2114-0419</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Теплякова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Teplyakova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Теплякова Ольга Вячеславовна — доктор медицинских наук, профессор, профессор кафедры поликлинической терапии, ультразвуковой и функциональной диагностики</p><p>Екатеринбург</p><p> </p></bio><bio xml:lang="en"><p>Olga V. Teplyakova, MD, PhD, DSc, Professor, Professor of the Department of Outpatient Therapy, Ultrasound and Functional Diagnostics, Faculty of General Medicine </p><p>Ekaterinburg</p></bio><email xlink:type="simple">oteplyakova69@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9004-3711</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гришина</surname><given-names>И. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Grishina</surname><given-names>I. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гришина Ирина Федоровна — доктор медицинских наук, профессор, заведующая кафедрой поликлинической терапии, ультразвуковой и функциональной диагностики</p><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Irina F. Grishina, MD, PhD, DSc, Professor, Head, Department of Outpatient Therapy, Ultrasound and Functional Diagnostics, Faculty of General Medicine </p><p>Ekaterinburg</p></bio><email xlink:type="simple">grishif@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3717-9281</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Клепикова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Klepikova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Клепикова Анна Алексеевна — студент 6-го курса лечебнопрофилактического факультета</p><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Anna A. Klepikova, 6th Year Student, Faculty of General Medicine </p><p>Ekaterinburg</p></bio><email xlink:type="simple">annaklepikova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение высшего образования «Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ural State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>26</day><month>11</month><year>2020</year></pub-date><volume>26</volume><issue>6</issue><fpage>676</fpage><lpage>687</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Полетаева Н.Б., Теплякова О.В., Гришина И.Ф., Клепикова А.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Полетаева Н.Б., Теплякова О.В., Гришина И.Ф., Клепикова А.А.</copyright-holder><copyright-holder xml:lang="en">Poletaeva N.B., Teplyakova O.V., Grishina I.F., Klepikova A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/1933">https://htn.almazovcentre.ru/jour/article/view/1933</self-uri><abstract><p>Цель исследования — проанализировать особенности церебрального кровотока у пациентов с хронической обструктивной болезнью легких (ХОБЛ), ассоциированной с артериальной гипертензией (АГ). Материалы и методы. Проведено одномоментное кросс-секционное исследование, в которое вошли 90 лиц мужского пола 40–60 лет. Из них 30 пациентов с ХОБЛ, ассоциированной с АГ (ХОБЛ + АГ), вошли в группу исследования, 30 лиц с изолированной ХОБЛ составили группу сравнения, 30 здоровых добровольцев вошли в группу контроля. Всем участникам были проведены физикальное исследование, спирография, суточное мониторирование артериального давления (АД), ультразвуковое исследование церебральных сосудов.  Результаты. У пациентов с ХОБЛ + АГ в сравнении с контролем наблюдалось увеличение диаметра (p = 0,018) и комплекса интима-медиа общей сонной артерии (p = 0,003) при отсутствии изменения скоростных показателей, индекса резистентности (RI) и пульсационного индекса (PI). В бассейне внутренней сонной артерии отмечался рост значений RI (p = 0,018). На интракраниальном уровне наблюдалось снижение конечно-диастолической скорости (EDV) (p = 0,03) и усредненной по времени средней скорости кровотока (TAV) (p = 0,033) без должных изменений RI и PI. При этом в бассейне позвоночной артерии изменений скоростных показателей и индексов не отмечалось. Среди показателей церебральной перфузии у лиц с ХОБЛ + АГ статистически значимо возрастали гидродинамическое сопротивление (p = 0,0015), внутричерепное давление (ВЧД) (p = 0,0048), при этом индекс церебрального кровотока (ИЦК) был сопоставим с контролем. Оценка венозного мозгового кровотока показала рост диаметра внутренней яремной вены (p = 0,021) при неизмененных TAV вместе с повышением ВЧД, свидетельствующие о формировании венозной дисфункции. Также было показано, что индекс массы тела, объем форсированного выдоха за первую секунду, систолическое и диастолическое АД в совокупности определяют пиковую систолическую скорость кровотока в среднемозговой артерии. Заключение. Мозговой кровоток у пациентов с ХОБЛ + АГ характеризуется изменением артериального кровотока на уровне как интра-, так и экстракраниальных сосудов, при сохранении нормального ИЦК, а также формированием артериовенозной дисгемии, на фоне ремоделирования церебрального сосудистого русла.</p></abstract><trans-abstract xml:lang="en"><p>Objective. The aim of the work was to study the features of cerebral blood flow in patients with chronic obstructive pulmonary disease (COPD) associated with hypertension (HTN).  Design and methods. A crosssectional study was conducted, which included 90 males 40–60 years old. Of these, 30 patients with chronic COPD associated with HTN (COPD + HTN) were included in the study group, 30 individuals with isolated COPD were in the comparison group, 30 healthy volunteers were included in the control group. All participants underwent physical examination, spirography, 24-hour blood pressure monitoring and ultrasound examination of cerebral vessels.  Results. Patients with COPD + HTN in comparison with the control showed an increase in the diameter (p = 0,018) and complex of the intima-media of the common carotid artery (p = 0,003) while the velocities, resistance index (RI) and pulsation index (PI) did not change. In the basin of the internal carotid artery an increase in RI values was noted (p = 0,018). At the intracranial level there was a decrease in the end-diastolic velocity (p = 0,03) and the time-averaged average blood flow velocity (TAV) (p = 0,033) without due changes RI and PI. At the same time no changes in speed indicators and indices were noted in the vertebral artery basin. Among the indicators of cerebral perfusion in patients with COPD + HTN, hydrodynamic resistance (p = 0,0015), intracranial pressure (ICP) (p = 0,0048) significantly increased, and the cerebral blood flow index was comparable with the control. Assessment of venous cerebral blood flow showed an increase in the diameter of the internal jugular vein (p = 0,021) with unchanged TAV together with an increase in ICP indicating the formation of venous dysfunction. It was shown that the body mass index, forced expiratory volume at the first second, systolic and diastolic blood pressure together determine the peak systolic blood flow velocity from the midbrain artery.  Conclusions. The cerebral blood flow in patients with COPD + HTN is characterized by a change in arterial blood flow at the level of both intra- and extracranial vessels, while maintaining a normal cerebral blood flow index, as well as the formation of arteriovenous dyshemia against the background of remodeling of the cerebral vascular bed.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая обструктивная болезнь легких</kwd><kwd>артериальная гипертензия</kwd><kwd>мозговой&#13;
кровоток</kwd><kwd>ультразвуковое исследование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic obstructive pulmonary disease</kwd><kwd>hypertension</kwd><kwd>cerebral blood flow</kwd><kwd>ultrasound</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Camiciottoli G, Bigazzi F, Magni C, Bonti V, Diciotti S, Bartolucci M et al. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:2229–2236. doi:10.2147/COPD.S111724</mixed-citation><mixed-citation xml:lang="en">Camiciottoli G, Bigazzi F, Magni C, Bonti V, Diciotti S, Bartolucci M. et al. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016; 11: 2229–2236. doi: 10.2147/COPD.S111724</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Верткин А.Л., Скотников А.С., Тихоновская Е.Ю., Оралбекова Ж. М., Губжокова О. М. Коморбидность при ХОБЛ: роль хронического системного воспаления. Российский медицинский журнал. 2014;11:811–816. [Vertkin AL, Skotnikov AS, Tikhonovskaya EYu, Oralbekova ZhM, Gubzhokova OM. Comorbidity in COPD: the role of chronic systemic inflammation. Russ Med J. 2014;11:811–816. In Russian].</mixed-citation><mixed-citation xml:lang="en">Vertkin AL, Skotnikov AS, Tikhonovskaya EYu, Oralbekova ZhM, Gubzhokova OM. Comorbidity in COPD: the role of chronic systemic inflammation. Russian Medical Journal. 2014; 11:811-816. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Задионченко B. C., Погонченкова И. В., Гринева З. О., Нестеренко О.И., Холодкова Н.Б. Хроническое легочное сердце. Российский кардиологический журнал. 2003;4(42):6–11 [Zadionchenko VS, Pogonchenkova IV, Grineva ZO, Nesterenko OI, Holodkova NB. Chronic pulmonary heart. Russ J Cardiol. 2003;4(42):6–11. In Russian].</mixed-citation><mixed-citation xml:lang="en">Zadionchenko VS, Pogonchenkova IV, Grineva ZO, Nesterenko OI, Holodkova NB. Chronic pulmonary heart. Russian Journal of Cardiology. 2003; 4 (42): 6-11. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Шляхто Е. В., Конради А. О. Ремоделирование сердца при гипертонической болезни. Сердце. 2002;1(5):232–234. [Shlyakhto EV, Konradi AO. Remodeling of the heart with hypertension. Heart. 2002;1(5):232–234. In Russian].</mixed-citation><mixed-citation xml:lang="en">Shlyakhto EV, Konradi AO. Remodeling of the heart with hypertension. Heart. 2002; 1 (5): 232-234. In Russain</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Булдакова И.А., Григоренко А.А. Изменения артериального сосудистого русла при хронической обструктивной болезни легких. Дальневосточный медицинский журнал. 2011;4:115–118. [Buldakova IA, Grigorenko AA. Changes in the arterial vascular bed in chronic obstructive pulmonary disease. Far Eastern Med J. 2011;4:115–118. In Russian].</mixed-citation><mixed-citation xml:lang="en">Buldakova IA, Grigorenko AA. Changes in the arterial vascular bed in chronic obstructive pulmonary disease. Far Eastern Medical Journal. 2011; 4: 115-118. In Russain</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Гельцер Б.И., Бродская Т.А., Невзорова В.А. Артериальная ригидность и хроническая обструктивная болезнь легких: патофизиологические взаимосвязи и клиническое значение. Терапевтический архив. 2008;11:89–94. [Geltzer BI, Brodskaya TA, Nevzorova VA. Arterial stiffness and chronic obstructive pulmonary disease: pathophysiological relationships and clinical significance. Ther Arch. 2008;11:89–94. In Russian].</mixed-citation><mixed-citation xml:lang="en">Geltzer BI, Brodskaya TA, Nevzorova VA. Arterial stiffness and chronic obstructive pulmonary disease: pathophysiological relationships and clinical significance. Therapeutic Archive. 2008; 11: 89-94. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Назарова О. А., Назарова А. В. Поражение сосудов при артериальной гипертензии. Вестник Ивановской медицинской академии. 2012;17(2):60–66. [Nazarova OA, Nazarova AV. Vascular damage in arterial hypertension. Bull Ivanovo Med Acad. 2012;17(2):60–66. In Russian].</mixed-citation><mixed-citation xml:lang="en">Nazarova OA, Nazarova AV. Vascular damage in arterial hypertension. Bulletin of the Ivanovo Medical Academy. 2012; 17 (2): 60-66. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Бродская Т.А., Невзорова В.А., Гельцер Б.И. Дисфункция эндотелия и болезни органов дыхания. Терапевтический архив. 2007;79(3):76–84. [Brodskaya TA, Nevzorova VA, Gelzer BI. Endothelial dysfunction and respiratory disease. Ther Arch. 2007;79(3):76–84. In Russian].</mixed-citation><mixed-citation xml:lang="en">Brodskaya TA, Nevzorova VA, Gelzer BI. Endothelial dysfunction and respiratory disease. Therapeutic Archive. 2007; 79 (3): 76-84. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Кунцевская И. В. Диагностика и лечение нарушений церебральной гемодинамики у больных с хроническим обструктивным заболеванием легких. Международный неврологический журнал. 2014;4(66):132–136. [Kuntsevskaya IV. Diagnosis and treatment of cerebral hemodynamic disorders in patients with chronic obstructive pulmonary disease. Int Neurol J. 2014;4(66):132–136. In Russian].</mixed-citation><mixed-citation xml:lang="en">Kuntsevskaya IV. Diagnosis and treatment of cerebral hemodynamic disorders in patients with chronic obstructive pulmonary disease. International Neurological Journal. 2014; 4 (66): 132-136. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Meissner A. Hypertension and the brain: a risk factor for more than heart disease. Cerebrovasc Dis. 2016;42(3–4):255–226. doi:10.1159/000446082</mixed-citation><mixed-citation xml:lang="en">Meissner A. Hypertension and the Brain: A Risk Factor for More Than Heart Disease. Cerebrovasc Dis. 2016; 42 (3-4): 255-26. Doi: 10.1159/000446082</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gan WQ, Man SF, Senthilselvan A, Sin DD. The association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574–580.</mixed-citation><mixed-citation xml:lang="en">Gan WQ, Man SF, Senthilselvan A, Sin DD. The association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax. 2004; 59: 574-580.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Никитин Ю.М., Белова Л.А., Машин В.В., Лопатко Д.Н., Белов В.Г. Клинико-неврологические и ультразвуковые критерии конституциональной венозной недостаточности при гипертонической энцефалопатии. Кремлевская медицина. Клинический вестник. 2010;4:12–15. [Nikitin YuM, Belova LA, Mashin VV, Lopatko DN, Belov VG. Clinical, neurological and ultrasound criteria for constitutional venous insufficiency in hypertensive encephalopathy. Kremlin Med. Clinical Herald. 2010;4:12–15. In Russian].</mixed-citation><mixed-citation xml:lang="en">Nikitin YuM, Belova LA, Mashin VV, Lopatko DN, Belov VG. Clinical, neurological and ultrasound criteria for constitutional venous insufficiency in hypertensive encephalopathy. Kremlin medicine. Clinical Herald. 2010; 4: 12–15. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Никитин Ю.М. Алгоритм ультразвуковой диагностики поражений функционально-морфологических уровней кровоснабжения головного мозга в неврологической практике. Журнал неврологии и психиатрии им. С.С. Корсакова. 2007;20:46– 49. [Nikitin YuM. Algorithm for ultrasound diagnosis of lesions of functional morphological levels of blood supply to the brain in neurological practice. J Neurol Psych S.S. Korsakova. 2007;20:46– 49. In Russian].</mixed-citation><mixed-citation xml:lang="en">Nikitin YuM. Algorithm for ultrasound diagnosis of lesions of functional morphological levels of blood supply to the brain in neurological practice. Journal of Neurology and Psychiatry. S.S. Korsakova. 2007; 20: 46-49. In Russain</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Никитин Ю.М., Труханов А.И. Ультразвуковая доплеровская диагностика в клинике. Иваново: МИК; 2004. 496 c.</mixed-citation><mixed-citation xml:lang="en">Nikitin Yu.M., Trukhanov A.I. Ultrasound Doppler diagnostics in the clinic. Ivanovo: MIC; 2004.496 p.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Belfort MA. Association of cerebral perfusion pressure with headache in women with pre-eclampsia. Br J Obstet Gynaecol. 1999;106(8):814–821. doi:10.1111/j.1471-0528.1999.tb08403.x</mixed-citation><mixed-citation xml:lang="en">Belfort MA. Association of cerebral perfusion pressure with headache in women with pre-eclampsia. British Journal of Obstetics and Gynaecology August.  1999; 106: 814-821. doi: 10.1111/j.1471-0528.1999.tb08403.x</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Evans DH. Resistance index, blood flow velocity, and resistance-area product in the cerebral arteries of very low birth weight infants during the first week of life. Ultrasound Med Biol. 1988;14(2):103–110. doi:10.1016/0301-5629(88)90176-7</mixed-citation><mixed-citation xml:lang="en">Evans DH. Resistance index, blood flow velocity, and resistance-area product in the cerebral arteries of very low birth weight infants during the first week of life. Ultrasound Med Biol.  1988; 14 (2): 103-110. doi: 10.1016/0301-5629(88)90176-7</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Williams KP. Persistence of cerebral hemodynamic changes in patients with eclampsia: a report of three cases. Am J Obstet Gynaecol. 1999;181(5Pt1):1162–1165. doi:10.1016/s0002-9378(99)70101-8</mixed-citation><mixed-citation xml:lang="en">Williams  KP. Persistence of cerebral hemodynamic changes in patients with eclampsia: A report of three cases. American Journal of Obstetrics and Gynecololgy. 1999; 181: 1162-1165. doi: 10.1016/s0002-9378(99)70101-8</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Klingelhöfer J, Conrad B, Benecke R, Sander D, Markakis E. Evaluation of intracranial pressure from transcranial Doppler studies in cerebral disease. Stroke. 1988;235(3):159–162. doi:10.1007/bf00314307</mixed-citation><mixed-citation xml:lang="en">Klingelhöfer J. Evaluation of intracranial pressure from transcranial Doppler studies in cerebral disease. Stroke. 1988; 235: 159-62. doi: 10.1007/bf00314307</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Willie CK, Tzeng YC, Fisher JA, Ainslie PN. Integrative regulation of human brain blood flow. J Physiol. 2014;592(5):841– 859. doi:10.1113/jphysiol.2013.268953</mixed-citation><mixed-citation xml:lang="en">Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R. COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clinical Science. Portland Press Ltd. 2016; 130 (13): 1039-1050. doi: 10.1042/CS20160043</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">ter Laan M, van Dijk JM, Elting JW, Staal MJ, Absalom AR. Sympathetic regulation of cerebral blood flow in humans: a review. Br J Anaesth. 2013;111(3):361–367. doi:10.1093/bja/aet122</mixed-citation><mixed-citation xml:lang="en">Geltser BI, Kurpatov IG, Kotelnikov VN, Zayats YuV. Chronic obstructive pulmonary disease and cerebrovascular disease: structural, functional and clinical aspects of comorbidity. Therapeutic Archive. 2018; 3: 81-88. In Russain</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lahousse L, Vernooij MW, Darweesh SK, Akoudad S, Loth DW, Joos GF et al. Chronic obstructive pulmonary disease and cerebral microbleeds. The Rotterdam Study. Am J Respir Crit Care Med. 2013;188(7):783–788. doi:10.1164/rccm.201303-0455OC</mixed-citation><mixed-citation xml:lang="en">Henry-Feugeas MC, Koskas P. Cerebral vascular aging: extending the concept of pulse wave encephalopathy through capillaries to the cerebral veins. Curr. Aging Sci. 2012; 5 (2): 157–167. doi: 10.2174/1874609811205020157</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Maclay JD, MacNee W. Cardiovascular disease in COPD: mechanisms. Chest. 2013;143(3):798–807. doi:10.1378/chest.12-0938</mixed-citation><mixed-citation xml:lang="en">Moody DM, Brown WR, Challa VR, Anderson RL. Periventricular venous collagenosis: association with leukoaraiosis. Radiology. 1995; 194 (2): 469–476. doi: 10.1148/radiology.194.2.7824728</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Замечник Т. В., Рогова Л. Н. Гипоксия как пусковой фактор развития эндотелиальной дисфункции и воспаления сосудистой стенки (обзор литературы). Вестник новых медицинских технологий. 2012;19(2):393–394. [Observer TV, Rogova LN. Hypoxia as a trigger factor in the development of endothelial dysfunction and inflammation of the vascular wall (review). Bull New Med Tech. 2012;19(2):393–394. In Russian].</mixed-citation><mixed-citation xml:lang="en">Замечник Т. В., Рогова Л. Н. Гипоксия как пусковой фактор развития эндотелиальной дисфункции и воспаления сосудистой стенки (обзор литературы). Вестник новых медицинских технологий. 2012;19(2):393–394. [Observer TV, Rogova LN. Hypoxia as a trigger factor in the development of endothelial dysfunction and inflammation of the vascular wall (review). Bull New Med Tech. 2012;19(2):393–394. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Грищенко О.О., Бродовская Т.О. К вопросу о влиянии обструктивного апноэ сна на церебральную гемодинамику в контексте концепции раннего старения. Российский кардиологический журнал. 2019;4S2(24):27. doi:10.15829/1560–4071– 2019-s2. [Grishchenko OO, Brodovskaya TO. On the effect of obstructive sleep apnea on cerebral hemodynamics in the context of the concept of early aging. Russ J Cardiol. 2019;4S 2(24):27. doi:10.15829/1560-4071-2019-s2. In Russian].</mixed-citation><mixed-citation xml:lang="en">Грищенко О.О., Бродовская Т.О. К вопросу о влиянии обструктивного апноэ сна на церебральную гемодинамику в контексте концепции раннего старения. Российский кардиологический журнал. 2019;4S2(24):27. doi:10.15829/1560–4071– 2019-s2. [Grishchenko OO, Brodovskaya TO. On the effect of obstructive sleep apnea on cerebral hemodynamics in the context of the concept of early aging. Russ J Cardiol. 2019;4S 2(24):27. doi:10.15829/1560-4071-2019-s2. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R. COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clinical Science. Portland Press Ltd. 2016;130(13):1039–1050. doi:10.1042/CS20160043</mixed-citation><mixed-citation xml:lang="en">Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R. COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clinical Science. Portland Press Ltd. 2016;130(13):1039–1050. doi:10.1042/CS20160043</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Гельцер Б. И., Курпатов И. Г., Котельников В. Н., Заяц Ю. В. Хроническая обструктивная болезнь легких и цереброваскулярные заболевания: структурно-функциональные и клинические аспекты коморбидности. Терапевтический архив. 2018;90(3):81–88. [Geltser BI, Kurpatov IG, Kotelnikov VN, Zayats Yu V. Chronic obstructive pulmonary disease and cerebrovascular disease: structural, functional and clinical aspects of comorbidity. Ther Arch. 2018;90(3):81–88. In Russian].</mixed-citation><mixed-citation xml:lang="en">Гельцер Б. И., Курпатов И. Г., Котельников В. Н., Заяц Ю. В. Хроническая обструктивная болезнь легких и цереброваскулярные заболевания: структурно-функциональные и клинические аспекты коморбидности. Терапевтический архив. 2018;90(3):81–88. [Geltser BI, Kurpatov IG, Kotelnikov VN, Zayats Yu V. Chronic obstructive pulmonary disease and cerebrovascular disease: structural, functional and clinical aspects of comorbidity. Ther Arch. 2018;90(3):81–88. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Incalza MA, D’Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018;100:1–19. doi:10.1016/j.vph.2017.05.005</mixed-citation><mixed-citation xml:lang="en">Incalza MA, D’Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018;100:1–19. doi:10.1016/j.vph.2017.05.005</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Varghese JF, Patel R, Yadav UCS. Novel insights in the metabolic syndrome-induced oxidative stress and inflammationmediated atherosclerosis. Curr Cardiol Rev. 2018;14(1):4–14.</mixed-citation><mixed-citation xml:lang="en">Varghese JF, Patel R, Yadav UCS. Novel insights in the metabolic syndrome-induced oxidative stress and inflammationmediated atherosclerosis. Curr Cardiol Rev. 2018;14(1):4–14.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Caramori G, Kirkham P, Barczyk A, Di Stefano A, Adcock I. Molecular pathogenesis of cigarette smoking-induced stable COPD. Ann N Y Acad Sci. 2015;1340:55–64. doi:10.1111/nyas.12619</mixed-citation><mixed-citation xml:lang="en">Caramori G, Kirkham P, Barczyk A, Di Stefano A, Adcock I. Molecular pathogenesis of cigarette smoking-induced stable COPD. Ann N Y Acad Sci. 2015;1340:55–64. doi:10.1111/nyas.12619</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Szucs B, Szucs C, Petrekanits M, Varga JT. Molecular characteristics and treatment of endothelial dysfunction in patients with COPD: A Review Article. Int J Mol Sci. 2019;20(18):4329. doi:10.3390/ijms20184329</mixed-citation><mixed-citation xml:lang="en">Szucs B, Szucs C, Petrekanits M, Varga JT. Molecular characteristics and treatment of endothelial dysfunction in patients with COPD: A Review Article. Int J Mol Sci. 2019;20(18):4329. doi:10.3390/ijms20184329</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Berg K, Wright, JL. The pathology of chronic obstructive pulmonary disease: progress in the 20th and 21st centuries. Arch Pathol Lab Med. 2016;140(12):1423–1428. doi:10.5858/arpa.2015-0455-rs</mixed-citation><mixed-citation xml:lang="en">Berg K, Wright, JL. The pathology of chronic obstructive pulmonary disease: progress in the 20th and 21st centuries. Arch Pathol Lab Med. 2016;140(12):1423–1428. doi:10.5858/arpa.2015-0455-rs</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Монгирдиене А., Виежелиене Д., Куршветене Л. Воздействие никотина и смол, находящихся в табачном дыме, на процесс атерогенеза. Кардиология. 2012;52(9):87–93. [Mongirdiene A, Viezhelien D, Kursvetene L. The effect of nicotine and tar contained in tobacco smoke on the process of atherogenesis. Cardiology. 2012;52(9):87–93. In Russian].</mixed-citation><mixed-citation xml:lang="en">Монгирдиене А., Виежелиене Д., Куршветене Л. Воздействие никотина и смол, находящихся в табачном дыме, на процесс атерогенеза. Кардиология. 2012;52(9):87–93. [Mongirdiene A, Viezhelien D, Kursvetene L. The effect of nicotine and tar contained in tobacco smoke on the process of atherogenesis. Cardiology. 2012;52(9):87–93. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Sordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 2013;10(4):219–230. doi:10.1038/nrcardio.2013.8</mixed-citation><mixed-citation xml:lang="en">Sordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 2013;10(4):219–230. doi:10.1038/nrcardio.2013.8</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">van Gestel AJ, Kohler M, Clarenbach CF. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD). Discov Med. 2012;14(79): 359–368.</mixed-citation><mixed-citation xml:lang="en">van Gestel AJ, Kohler M, Clarenbach CF. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD). Discov Med. 2012;14(79): 359–368.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ogoh S. Interaction between the respiratory system and cerebral blood flow regulation. J Appl Physiol. 2019;127(5):1197– 1205. doi:10.1152/japplphysiol.00057.2019</mixed-citation><mixed-citation xml:lang="en">Ogoh S. Interaction between the respiratory system and cerebral blood flow regulation. J Appl Physiol. 2019;127(5):1197– 1205. doi:10.1152/japplphysiol.00057.2019</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Cipolla MJ, Liebeskind DS, Chan SL. The importance of comorbidities in ischemic stroke: Impact of hypertension on the cerebral circulation. J Cereb Blood Flow Metab. 2018;38(12):2129–2149. doi:10.1177/0271678X18800589</mixed-citation><mixed-citation xml:lang="en">Cipolla MJ, Liebeskind DS, Chan SL. The importance of comorbidities in ischemic stroke: Impact of hypertension on the cerebral circulation. J Cereb Blood Flow Metab. 2018;38(12):2129–2149. doi:10.1177/0271678X18800589</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Hussain M, Awan FR. Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease. Clin Exp Hypertens. 2018;40(4):344–352. doi:10.1080/10641963.2017.1377218</mixed-citation><mixed-citation xml:lang="en">Hussain M, Awan FR. Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease. Clin Exp Hypertens. 2018;40(4):344–352. doi:10.1080/10641963.2017.1377218</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V et al. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev. 2018;98(3):1627–1738. doi:10.1152/physrev.00038.2017</mixed-citation><mixed-citation xml:lang="en">Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V et al. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev. 2018;98(3):1627–1738. doi:10.1152/physrev.00038.2017</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Kaparianos A, Argyropoulou E. Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome. Curr Med Chem. 2011;18(23):3506–3515. doi:10.2174/092986711796642562</mixed-citation><mixed-citation xml:lang="en">Kaparianos A, Argyropoulou E. Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome. Curr Med Chem. 2011;18(23):3506–3515. doi:10.2174/092986711796642562</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Henry-Feugeas MC, Koskas P. Cerebral vascular aging: extending the concept of pulse wave encephalopathy through capillaries to the cerebral veins. Curr Aging Sci. 2012;5(2):157– 167. doi:10.2174/1874609811205020157</mixed-citation><mixed-citation xml:lang="en">Henry-Feugeas MC, Koskas P. Cerebral vascular aging: extending the concept of pulse wave encephalopathy through capillaries to the cerebral veins. Curr Aging Sci. 2012;5(2):157– 167. doi:10.2174/1874609811205020157</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Tong LS, Guo ZN, Ou YB, Yu YN, Zhan XC, Tang J et al. Cerebral venous collaterals: a new fort for fighting ischemic stroke? Prog Neurobiol. 2018;163–164:172–193. doi:10.1016/j.pneurobio.2017.11.001</mixed-citation><mixed-citation xml:lang="en">Tong LS, Guo ZN, Ou YB, Yu YN, Zhan XC, Tang J et al. Cerebral venous collaterals: a new fort for fighting ischemic stroke? Prog Neurobiol. 2018;163–164:172–193. doi:10.1016/j.pneurobio.2017.11.001</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Moody DM, Brown WR, Challa VR, Anderson RL. Periventricular venous collagenosis: association with leukoaraiosis. Radiology. 1995;194(2):469–476. doi:10.1148/radiology.194.2.7824728</mixed-citation><mixed-citation xml:lang="en">Moody DM, Brown WR, Challa VR, Anderson RL. Periventricular venous collagenosis: association with leukoaraiosis. Radiology. 1995;194(2):469–476. doi:10.1148/radiology.194.2.7824728</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Ives SJ, Harris RA, Witman MA, Fjeldstad AS, Garten RS, McDaniel J et al. Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension. 2014;63(3):459–467. doi:10.1161/HYPERTENSIONAHA.113.02255</mixed-citation><mixed-citation xml:lang="en">Ives SJ, Harris RA, Witman MA, Fjeldstad AS, Garten RS, McDaniel J et al. Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension. 2014;63(3):459–467. doi:10.1161/HYPERTENSIONAHA.113.02255</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Fulop GA, Tarantini S, Yabluchanskiy A, Molnar A, Prodan CI, Kiss T et al. Role of age-related alterations of the cerebral venous circulation in the pathogenesis of vascular cognitive impairment. Am J Physiol Heart Circ Physiol. 2019;316(5):1124– 1140. doi:10.1152/ajpheart.00776.2018</mixed-citation><mixed-citation xml:lang="en">Fulop GA, Tarantini S, Yabluchanskiy A, Molnar A, Prodan CI, Kiss T et al. Role of age-related alterations of the cerebral venous circulation in the pathogenesis of vascular cognitive impairment. Am J Physiol Heart Circ Physiol. 2019;316(5):1124– 1140. doi:10.1152/ajpheart.00776.2018</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
